Chimerix Reports Fourth Quarter and Year End 2021 Financial Results and Provides Operational Update
Published on: Monday 28 February 2022
Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission it is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today reported financial ...